✦ LIBER ✦

Nephrogenic systemic fibrosis: is any contrast safe in renal failure?

✍ Scribed by Z. H. Endre

Book ID: 109002055
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 56 KB
Volume: 37
Category: Article
ISSN: 1444-0903
DOI: 10.1111/j.1445-5994.2007.01401.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conventional or Gadolinium containing co

Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?

✍ Alexander R. Rosenkranz; Thomas Grobner; Gert J. Mayer 📂 Article 📅 2007 🏛 Springer Vienna 🌐 English ⚖ 138 KB

What is the role of renal transplantatio

What is the role of renal transplantation in a patient with nephrogenic systemic fibrosis?

✍ Mandip Panesar; Rabi Yacoub 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Nephrogenic systemic fibrosis versus con

Nephrogenic systemic fibrosis versus contrast-induced nephropathy: Risks and benefits of contrast-enhanced MR and CT in renally impaired patients

✍ Diego R. Martin; Richard C. Semelka; Arlene Chapman; Harm Peters; Paul J. Finn; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract Magnetic resonance imaging (MRI) and computed tomography (CT) have become essential to diagnostic evaluation of many, or most, important medically and surgically treated diseases. It is important to consider comprehensively the implications in making decisions when choosing one or the o

NSF: WHAT WE KNOW AND WHAT WE NEED TO KN

NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis: A Sufficient Reason to Avoid Gadolinium-Based Contrast in All Patients with Renal Impairment?

✍ Michelle Willicombe; John Cunningham 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Retrospective assessment of prevalence o

Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients

✍ Hani H. Abujudeh; Hillary Rolls; Rathachai Kaewlai; Sheela Agarwal; Zelalem A. G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract From May 2007 to January 2008, patients with Stage 3‐5 chronic kidney disease (CKD) undergoing gadobenate dimeglumine (GBD)‐enhanced magnetic resonance (MR) examinations were included in the retrospective investigation. The electronic medical records were reviewed to assess the prevalen